BGNE - BeiGene, Ltd.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 57.23B
Enterprise Value 36.01B
Trailing P/E N/A
Forward P/E 1-10.23
PEG Ratio (5 yr expected) 1-0.42
Price/Sales (ttm)29.67
Price/Book (mrq)4.57
Enterprise Value/Revenue 324.67
Enterprise Value/EBITDA 6-7.93

Trading Information

Stock Price History

Beta (3Y Monthly) 1.19
52-Week Change 3-24.81%
S&P500 52-Week Change 37.70%
52 Week High 3194.56
52 Week Low 3105.19
50-Day Moving Average 3122.73
200-Day Moving Average 3130.73

Share Statistics

Avg Vol (3 month) 3294.89k
Avg Vol (10 day) 3243.77k
Shares Outstanding 559.9M
Float 30.73M
% Held by Insiders 10.03%
% Held by Institutions 188.60%
Shares Short (Jun 28, 2019) 44.06M
Short Ratio (Jun 28, 2019) 413.69
Short % of Float (Jun 28, 2019) 4N/A
Short % of Shares Outstanding (Jun 28, 2019) 46.78%
Shares Short (prior month May 31, 2019) 43.63M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-315.68%

Management Effectiveness

Return on Assets (ttm)-24.76%
Return on Equity (ttm)-49.44%

Income Statement

Revenue (ttm)243.51M
Revenue Per Share (ttm)4.24
Quarterly Revenue Growth (yoy)139.20%
Gross Profit (ttm)-509.49M
EBITDA -757.16M
Net Income Avi to Common (ttm)-736.81M
Diluted EPS (ttm)-12.83
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.61B
Total Cash Per Share (mrq)26.99
Total Debt (mrq)270.59M
Total Debt/Equity (mrq)16.67
Current Ratio (mrq)7.52
Book Value Per Share (mrq)26.91

Cash Flow Statement

Operating Cash Flow (ttm)-615.19M
Levered Free Cash Flow (ttm)-523.54M